The long-term goal of this project is to define the role of the novel lipid pathway mediated by sphingosine-1- phosphate (S1P) in inflammation and to establish components of this pathway as potential novel targets for anti-inflammatory therapy. The Pi's laboratory has an established track record of expertise in sphingolipid metabolism and function. Studies from the previous funding period have led us into a novel exciting direction on the role and regulation of S1P in inflammation. S1P is generated by phosphorylation by sphingosine kinase (SK) in many cell types including inflammatory cells. SIP acts extracellularly by binding to members of the G-protein coupled receptors S1Pi.5l or intracellularly on poorly defined targets. It mediates several biologic activities, including mitogenesis, cell survival, angiogenesis and inflammatory responses. In this competing renewal we have compelling new data, whereby we have implicated this pathway as a key regulator of cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) production. In addition we find that SK1 is significantly overexpressed in inflammatory tissues. We also demonstrate that bacterial lipopolysaccharide (LPS) regulates SK1. This proposal will therefore, test the hypothesis that SK1 and S1P regulate inflammation, and that inhibiting this pathway could inhibit inflammatory responses. To test this hypothesis we propose the following aims: 1) Establish that the SK1 and S1Ppathway is regulated in inflammation and determine the mechanisms of this regulation. This will be done by determining if this pathway is regulated in inflammation and studying the mechanisms of this regulation in cell models of inflammation, and by determining the expression and cell-type distribution of SK1 in inflammatory tissues from humans and from animal models of inflammation. 2) Establish the function of SK1 and S1P in regulation of inflammation and determine the mechanisms of action of this pathway. This will bedone by demonstrating that SK1 and S1P have a significant role in regulating inflammation by evaluating the effect of over expression of SK1 and of S1P treatment in cells and in vivo models of inflammation, and determining the mechanisms by which SK1 and S1P regulate inflammatory pathways (NF-KB, IL2, TNF, ERKs, COX-2). 3) Determine if SK1 and S1P are necessary for inflammation. This will be done by blocking SK1 activity in cells and in vivo using small interfering RNA to SK1 and/or dominant negative SK1. In addition we will test different compounds that we synthesized for their ability to inhibit SK1 or to antagonize S1P receptors in cells and in vivo models of inflammation. These studies will enable us to gain important insight into the role of this pathway in inflammatory responses and may also provide novel therapeutic approaches to inflammation.
| Schwartz, Nicholas U; Linzer, Ryan W; Truman, Jean-Philip et al. (2018) Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F. FASEB J 32:1716-1728 |
| Carroll, Brittany L; Bonica, Joseph; Shamseddine, Achraf A et al. (2018) A role for caspase-2 in sphingosine kinase 1 proteolysis in response to doxorubicin in breast cancer cells - implications for the CHK1-suppressed pathway. FEBS Open Bio 8:27-40 |
| Williams, Bianca; Correnti, Jason; Oranu, Amanke et al. (2018) A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis. FASEB J 32:130-142 |
| Senkal, Can E; Salama, Mohamed F; Snider, Ashley J et al. (2017) Ceramide Is Metabolized to Acylceramide and Stored in Lipid Droplets. Cell Metab 25:686-697 |
| Carroll, Brittany L; Pulkoski-Gross, Michael J; Hannun, Yusuf A et al. (2016) CHK1 regulates NF-?B signaling upon DNA damage in p53- deficient cells and associated tumor-derived microvesicles. Oncotarget 7:18159-70 |
| Carroll, Brittany; Donaldson, Jane Catalina; Obeid, Lina (2015) Sphingolipids in the DNA damage response. Adv Biol Regul 58:38-52 |
| Salama, Mohamed F; Carroll, Brittany; Adada, Mohamad et al. (2015) A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma. FASEB J 29:2803-13 |
| Adada, Mohamad; Canals, Daniel; Hannun, Yusuf A et al. (2014) Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications for cell dynamics. Biochim Biophys Acta 1841:727-37 |
| Snider, Ashley J; Ali, Wahida H; Sticca, Jonathan A et al. (2014) Distinct roles for hematopoietic and extra-hematopoietic sphingosine kinase-1 in inflammatory bowel disease. PLoS One 9:e113998 |
| Adada, Mohamad; Canals, Daniel; Hannun, Yusuf A et al. (2013) Sphingosine-1-phosphate receptor 2. FEBS J 280:6354-66 |
Showing the most recent 10 out of 65 publications
